{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:29:16Z","timestamp":1793042956506,"version":"4.5.0"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:sec id=\"ab-srv220004-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Definitive treatment of primary hyperparathyroidism (pHPT) with curative parathyroidectomy has been shown to improve nonspecific neurocognitive symptoms and may improve long-term quality of life (QOL). However, QOL is not currently routinely assessed preoperatively, and as a result, diminished QOL may be overlooked as an indication for surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv220004-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine results for measures of long-term QOL after parathyroidectomy in patients with pHPT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv220004-6\">\n                    <jats:title>Evidence Review<\/jats:title>\n                    <jats:p>\n                      A systematic, English-language literature review was performed to assess the long-term association of parathyroidectomy, defined as a minimum of 1-year postoperative follow-up, with QOL in patients with pHPT. We conducted a search of PubMed and Scopus using Medical Subject Heading (MeSH) terms for\n                      <jats:italic>hyperparathyroidism<\/jats:italic>\n                      ,\n                      <jats:italic>parathyroid hormone<\/jats:italic>\n                      ,\n                      <jats:italic>parathyroidectomy<\/jats:italic>\n                      ,\n                      <jats:italic>hypercalcemia<\/jats:italic>\n                      , and\n                      <jats:italic>quality of life<\/jats:italic>\n                      . All relevant literature published between June 1998 and February 15, 2021, was included. Study selection was guided by the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) strategy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv220004-7\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Thirty-one studies conducted in 14 countries with a minimum of 1 year of follow-up were included, comprising 3298 patients with pHPT (2975 underwent parathyroidectomy; 323 were observed), 5445 age- and sex-matched control participants, and 386 control patients with benign thyroid disease. To assess QOL, 21 studies (68%) used a general tool, the 36-item Short Form Survey (SF-36), and 8 (26%) used the disease-specific tool Parathyroidectomy Assessment of Symptoms (PAS). The remaining studies used a combination of 10 additional QOL tools. The median follow-up period was 1 year (range, 1-10 years). Of the 31 studies, 27 (87%) demonstrated significant score improvement in long-term QOL after parathyroidectomy, including 1 study that showed continued improvement in QOL 10 years after parathyroidectomy. The remaining 4 studies (13%) reported mixed results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv220004-8\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This systematic review suggests that parathyroidectomy is associated with improved and sustained QOL in patients with pHPT. Patients with pHPT should be screened with a validated QOL tool such as the SF-36 or PAS at the time of diagnosis to guide discussion of these symptoms in the preoperative setting and the potential for long-term improvement after curative parathyroidectomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2022.4249","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T11:01:28Z","timestamp":1663153288000},"page":"1051","source":"Crossref","is-referenced-by-count":50,"title":["Long-term Quality of Life After Parathyroidectomy for Primary Hyperparathyroidism"],"prefix":"10.1001","volume":"157","author":[{"given":"Jennifer","family":"Livschitz","sequence":"first","affiliation":[{"name":"Department of Surgery, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina W. F.","family":"Yen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy S.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dream","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"srv220004r1","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/01.sla.0000120072.85692.a7","article-title":"The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?","volume":"239","author":"Eigelberger","year":"2004","journal-title":"Ann Surg"},{"issue":"9684","key":"srv220004r2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism.","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"srv220004r3","doi-asserted-by":"publisher","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism.","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"21","key":"srv220004r4","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","article-title":"The study of hyperparathyroidism at the Massachusetts General Hospital.","volume":"274","author":"Cope","year":"1966","journal-title":"N Engl J Med"},{"issue":"6","key":"srv220004r5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism.","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"srv220004r6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism.","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"srv220004r7","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary hyperparathyroidism.","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"srv220004r8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","article-title":"Asymptomatic primary hyperparathyroidism.","volume":"16","author":"Silverberg","year":"2013","journal-title":"J Clin Densitom"},{"issue":"10","key":"srv220004r9","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"srv220004r10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"6","key":"srv220004r11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.surg.2010.09.008","article-title":"Medication discontinuation after curative surgery for sporadic primary hyperparathyroidism.","volume":"148","author":"Melck","year":"2010","journal-title":"Surgery"},{"issue":"6","key":"srv220004r12","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.surg.2014.08.063","article-title":"Fibromyalgia symptoms and medication requirements respond to parathyroidectomy.","volume":"156","author":"Adkisson","year":"2014","journal-title":"Surgery"},{"issue":"3","key":"srv220004r13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.surg.2021.10.055","article-title":"Changes in frailty after parathyroid and thyroid surgery.","volume":"171","author":"McCoy","year":"2022","journal-title":"Surgery"},{"key":"srv220004r14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijsu.2014.12.004","article-title":"The extent of improvement of health-related quality of life as assessed by the SF36 and Paseika scales after parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis.","volume":"13","author":"Brito","year":"2015","journal-title":"Int J Surg"},{"issue":"12","key":"srv220004r15","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s00198-016-3715-3","article-title":"Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis.","volume":"27","author":"Singh Ospina","year":"2016","journal-title":"Osteoporos Int"},{"issue":"6","key":"srv220004r16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s40618-020-01447-7","article-title":"Efficacy of parathyroidectomy compared with active surveillance in patients with mild asymptomatic primary hyperparathyroidism: a systematic review and meta-analysis of randomized-controlled studies.","volume":"44","author":"Anagnostis","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"srv220004r17","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s00595-019-01830-9","article-title":"Effects of surgery on the patient-reported outcomes of primary hyperparathyroidism patients with mild hypercalcemia without classic symptoms: a systematic review of the literature.","volume":"50","author":"Horiuchi","year":"2020","journal-title":"Surg Today"},{"issue":"1","key":"srv220004r18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"srv220004r19","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"23","key":"srv220004r20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000931","article-title":"Quality of life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta-analysis of randomized controlled trials.","volume":"94","author":"Cheng","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"6846","key":"srv220004r21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36 health survey questionnaire: new outcome measure for primary care.","volume":"305","author":"Brazier","year":"1992","journal-title":"BMJ"},{"issue":"1","key":"srv220004r22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/jech.53.1.46","article-title":"Assessment of the SF-36 version 2 in the United Kingdom.","volume":"53","author":"Jenkinson","year":"1999","journal-title":"J Epidemiol Community Health"},{"issue":"9","key":"srv220004r23","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/archsurg.137.9.1022","article-title":"Surgical treatment of hyperparathyroidism improves health-related quality of life.","volume":"137","author":"Sheldon","year":"2002","journal-title":"Arch Surg"},{"issue":"11","key":"srv220004r24","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism.","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"srv220004r25","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"srv220004r26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.surg.2006.12.004","article-title":"Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up).","volume":"141","author":"Caillard","year":"2007","journal-title":"Surgery"},{"issue":"5","key":"srv220004r27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00268-008-9509-9","article-title":"Pasieka\u2019s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism.","volume":"32","author":"Mihai","year":"2008","journal-title":"World J Surg"},{"issue":"6","key":"srv220004r28","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1245\/s10434-008-9879-0","article-title":"The influence of surgical approach on quality of life after parathyroid surgery.","volume":"15","author":"Adler","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"srv220004r29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.amjsurg.2008.09.009","article-title":"Surgery improves quality of life in patients with \u201cmild\u201d hyperparathyroidism.","volume":"197","author":"Adler","year":"2009","journal-title":"Am J Surg"},{"issue":"7","key":"srv220004r30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00423-010-0689-z","article-title":"Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism.","volume":"395","author":"Gopinath","year":"2010","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"srv220004r31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/0022-3859.81859","article-title":"Salutary effect of parathyroidectomy on neuropsychiatric symptoms in patients with primary hyperparathyroidism: evaluation using PAS and SF-36v2 scoring systems.","volume":"57","author":"Ramakant","year":"2011","journal-title":"J Postgrad Med"},{"issue":"2","key":"srv220004r32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/2013.jamasurg.316","article-title":"Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study.","volume":"148","author":"Weber","year":"2013","journal-title":"JAMA Surg"},{"issue":"11","key":"srv220004r33","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1245\/s10434-014-3731-5","article-title":"Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study.","volume":"21","author":"Blanchard","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"srv220004r34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/EJE-14-0757","article-title":"Health-related quality of life after successful surgery for primary hyperparathyroidism: no additive effect from vitamin D supplementation: results of a double-blind randomized study.","volume":"172","author":"\u00c5berg","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"srv220004r35","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/hed.v38.8","article-title":"Impact of parathyroidectomy for primary hyperparathyroidism on quality of life: a case-control study using Short Form Health Survey 36.","volume":"38","author":"Dulfer","year":"2016","journal-title":"Head Neck"},{"issue":"3","key":"srv220004r36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/bjs.10739","article-title":"Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism.","volume":"105","author":"Bannani","year":"2018","journal-title":"Br J Surg"},{"issue":"1","key":"srv220004r37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.v36.1","article-title":"Effects of parathyroidectomy on quality of life: 10?years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-Study).","volume":"36","author":"Pretorius","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"1","key":"srv220004r38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1507\/endocrj.EJ20-0417","article-title":"The effect of parathyroidectomy on quality of life in primary hyperparathyroidism: evaluation with using sf-36 and phpqol questionnaire.","volume":"68","author":"Somuncu","year":"2021","journal-title":"Endocr J"},{"issue":"8","key":"srv220004r39","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s00268-002-6623-y","article-title":"Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism.","volume":"26","author":"Pasieka","year":"2002","journal-title":"World J Surg"},{"issue":"6","key":"srv220004r40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s002689900428","article-title":"Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism.","volume":"22","author":"Pasieka","year":"1998","journal-title":"World J Surg"},{"issue":"6","key":"srv220004r41","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.surg.2009.10.021","article-title":"The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study.","volume":"146","author":"Pasieka","year":"2009","journal-title":"Surgery"},{"issue":"1","key":"srv220004r42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/cen.13865","article-title":"Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: a prospective cohort study.","volume":"90","author":"Ejlsmark-Svensson","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"srv220004r43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1445-2197.2003.02907.x","article-title":"Pasieka Illness Questionnaire: its value in primary hyperparathyroidism.","volume":"74","author":"Greutelaers","year":"2004","journal-title":"ANZ J Surg"},{"issue":"4","key":"srv220004r44","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.surg.2006.06.016","article-title":"Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up.","volume":"140","author":"Edwards","year":"2006","journal-title":"Surgery"},{"issue":"2","key":"srv220004r45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jss.2007.01.027","article-title":"Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis.","volume":"140","author":"Egan","year":"2007","journal-title":"J Surg Res"},{"issue":"6","key":"srv220004r46","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s00268-007-9006-6","article-title":"Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism.","volume":"31","author":"Weber","year":"2007","journal-title":"World J Surg"},{"issue":"10","key":"srv220004r47","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1634\/theoncologist.2012-0203","article-title":"Changes in swallowing-related quality of life after parathyroidectomy for hyperparathyroidism: a prospective cohort study.","volume":"17","author":"Pinchot","year":"2012","journal-title":"Oncologist"},{"issue":"3","key":"srv220004r48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/EC-15-0053","article-title":"Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument.","volume":"4","author":"Ryh\u00e4nen","year":"2015","journal-title":"Endocr Connect"},{"issue":"10","key":"srv220004r49","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1055\/s-0043-118347","article-title":"Surgery significantly improves neurocognition, sleep, and blood pressure in primary hyperparathyroidism: a 3-year prospective follow-up study.","volume":"49","author":"Storvall","year":"2017","journal-title":"Horm Metab Res"},{"issue":"3","key":"srv220004r50","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/coa.2019.44.issue-3","article-title":"Quality of life improvement following parathyroid surgery: a preliminary 3-year review of 56 patients from a single surgical centre.","volume":"44","author":"Caton","year":"2019","journal-title":"Clin Otolaryngol"},{"issue":"1","key":"srv220004r51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1477-7525-11-97","article-title":"Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism.","volume":"11","author":"Webb","year":"2013","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"srv220004r52","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"srv220004r53","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1530\/EJE-11-0301","article-title":"Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls.","volume":"165","author":"Amstrup","year":"2011","journal-title":"Eur J Endocrinol"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2796289\/jamasurgery_livschitz_2022_rv_220004_1667884221.07217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T11:05:42Z","timestamp":1667991942000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2796289"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2022.4249","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}